Mercado mundial de dispositivos de biopsia asistida por vacío: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de dispositivos de biopsia asistida por vacío

La biopsia es un procedimiento que se utiliza para la extirpación quirúrgica de tejido de un órgano. El procedimiento se realiza para determinar la presencia o extensión de una enfermedad, incluidas las enfermedades inflamatorias y cancerosas. La prevalencia de enfermedades crónicas está acelerando el crecimiento del mercado de dispositivos de biopsia de mama.

Data Bridge Market Research analiza que el mercado global de dispositivos de biopsia asistida por vacío, que fue de USD 811,85 millones en 2022, probablemente alcance los USD 1.967,43 millones para 2030 y se espera que experimente una CAGR del 11,70% durante el período de pronóstico. Los "sistemas de biopsia asistida por vacío" dominan el segmento de productos del mercado debido a los avances en la tecnología. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de pacientes, análisis de la cartera de productos, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de dispositivos de biopsia asistida por vacío

Definición de mercado

Biopsy devices refer to the devices that are utilized for removing a piece of a sample or a tissue of cells from the body in order to analyze in the laboratory for presence of a disease. Vacuum-assisted biopsy refers to a minimum insertion system that offers extraction of multiple tissue specimens.

Vacuum Assisted Biopsy Devices Market Dynamics

Drivers

• Increasing incidence of breast cancer

The rising prevalence of breast cancer across the globe is driving the demand for vacuum-assisted biopsy devices. These devices are widely used for the diagnosis and staging of breast cancer, leading to an increased adoption in the market.

• Advancements in biopsy techniques

Technological advancements in biopsy techniques, such as vacuum-assisted biopsy, have improved the accuracy and efficiency of the procedure. This has resulted in a higher demand for vacuum-assisted biopsy devices, as they offer better sampling and reduced procedure time compared to traditional biopsy methods.

• Growing preference for minimally invasive procedures

Vacuum-assisted biopsy devices are minimally invasive, allowing for faster recovery, reduced scarring, and lower risk of complications compared to open surgical biopsies. As a result, there is a growing preference for these devices among both patients and healthcare providers, driving market growth.

Opportunities

• Increasing awareness and screening programs

The rising awareness about the importance of early detection and screening for various types of cancers, including breast cancer, has led to an increase in screening programs. Vacuum-assisted biopsy devices play a crucial role in these programs by providing accurate and reliable biopsy samples, will expected to contributing to market growth.

• Favourable reimbursement policies

Favourable reimbursement policies for vacuum-assisted biopsy procedures in many countries have positively impacted the market. These policies ensure that patients have access to affordable and high-quality healthcare services, including biopsy procedures, will expected to contributing to market growth

• Technological advancements in imaging techniques

The integration of vacuum-assisted biopsy devices with advanced imaging techniques, such as ultrasound and MRI, has improved the accuracy and precision of biopsies. This has further will fueled the adoption of vacuum-assisted biopsy devices in the market.

 Restraints/Challenges

• High cost of devices

Vacuum-assisted biopsy devices can be expensive, which may limit their adoption, particularly in developing countries with limited healthcare budgets. The high cost of these devices can also pose a financial burden on healthcare facilities and patients, hindering market growth.

• Lack of skilled professionals

Performing a vacuum-assisted biopsy requires specialized training and expertise. However, there is a shortage of skilled professionals, such as radiologists and surgeons, who are proficient in using these devices. This can restrict the widespread adoption of vacuum-assisted biopsy devices and limit market growth.

This vacuum assisted biopsy devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vacuum assisted biopsy devices market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2020, Hologic announced the launch of the Trident HD Specimen Radiography System, which is designed to enhance workflow and improve efficiency in breast-conserving surgeries and vacuum-assisted biopsies
• In February 2021, Medtronic announced the launch of the Achieve Advanced Enabling Technology for its Achieve Advanced Steerable Sheath. This technology provides enhanced control and access during vacuum-assisted biopsy procedures
• In 2019, Bard launched the EnCor Enspire Breast Biopsy System, which is a vacuum-assisted biopsy device designed to improve sample quality and streamline the biopsy process

Global Vacuum Assisted Biopsy Devices Market Scope

The vacuum assisted biopsy devices market is segmented on the basis product, type, technique, applications and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Vacuum-Assisted Biopsy Systems
• Vacuum-Assisted Biopsy Needles

Type

• 9-12G
• <9G
• >12G

Technique

• Ultrasound-Guided Biopsy
• Stereotactic-Guided Biopsy
• MRI-Guided Biopsy
• Others

Applications

• Breast Biopsy
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others

End User

• Hospitals
• Academic And Research Institutes
• Diagnostic And Imaging Centers
• Others

Vacuum Assisted Biopsy Devices Market Regional Analysis/Insights

The vacuum-assisted biopsy devices market is analyZed and market size insights and trends are provided by country, product, type, technique, applications and end user as referenced above.

The countries covered in the market  report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.

North America is expected to dominate the market due to the large availability of trained medical professionals and availability of well-developed infrastructure facilities within the region.

Asia-Pacific is expected to witness significant growth during the forecast period due to the surge in disposable income and rise in patient awareness toward disease screening in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The vacuum assisted biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for   vacuum assisted biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the vacuum assisted biopsy devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Vacuum Assisted Biopsy Devices Market Share Analysis

The vacuum assisted biopsy devices market competitive landscape provides details by competitor. details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. the above data points provided are only related to the companies' focus related to vacuum assisted biopsy devices market.

Some of the major players operating in the vacuum assisted biopsy devices market are:

• BD (U.S.)
• Cook (U.S.)
• Devicor Medical Products, Inc. (U.S.)
• ARGON MEDICAL. (U.S.)
• B. Braun Melsungen AG (Germany)
• Cardinal Health. (U.S.)
• Olympus Corporation (Japan)
• Boston Scientific Corporation (U.S.)
• FUJIFILM Corporation (Japan)
• INRAD Inc. (U.S.)
• Medtronic (Ireland)
• Hologic, Inc. (Estados Unidos)

SKU-52678